Henner Knust

USPTO Granted Patents = 68 (Patent Applications = 10)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 42 (Patent Applications = 42)

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 81(Granted Patents)

Inventors with similar research interests:

Location History:

Rheinfeiden, DE (2012)
Basel, CH (2021)
Rheinfelden, DE (2008 - 2024)

Company Filing History:

64 out of 4,942

Hoffmann-la Roche Inc.

Years Active: 2008-2024

Loading Chart...

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065399 - Arylsulfonamide derivatives (2024-08-20),

2. 11840528 - Isoxazolyl ether derivatives as GABAα5 PAM (2023-12-12),

3. 11358962 - 2-hetaryl imidazol[1,2-a]pyridine derivatives (2022-06-14),

4. 11091471 - Isoxazolyl ether derivatives as GABAα5 PAM (2021-08-17),

5. 11058781 - Diazacarbazole derivatives as tau-PET-ligands (2021-07-13),

6. 10975073 - Imaging methods using 2-hetaryl imidazol[1,2-a]pyridine derivatives (2021-04-13),

7. 10138234 - 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives (2018-11-27),

8. 10004817 - Diazacarbazole derivatives as tau-PET-ligands (2018-06-26),

9. 9957266 - Imidazo[1,2-a]pyridin-7-amine (2018-05-01),

10. 9801961 - 2-phenylimidazo[1,2-a]pyrimidines as imaging agents (2017-10-31),

11. 9346786 - Pyrrolidine compounds (2016-05-24),

12. 9260408 - Dihydroquinoline-2-one derivatives (2016-02-16),

13. 9226916 - Pyrrolidine derivatives (2016-01-05),

14. 9139593 - Azetidine compounds, compositions and methods of use (2015-09-22),

15. 9073908 - Isoxazolo-pyridine derivatives (2015-07-07),

Title: Henner Knust: Champion of Innovation and Sustainability

Introduction: Henner Knust, a prominent inventor based in Rheinfelden, DE, is known for his unwavering passion for innovation and his commitment to building a more sustainable future. With an impressive portfolio of 68 patents, Knust continues to inspire and influence the next generation of inventors and engineers worldwide.

Latest Patents:

1. Arylsulfonamide derivatives: Knust's groundbreaking invention introduces new arylsulfonamide compounds with significant potential in various applications. The compounds, characterized by the general formula (I), showcase Knust's expertise in developing novel solutions for complex challenges.

2. Isoxazolyl ether derivatives as GABAα5 PAM: Another remarkable patent by Knust includes novel compounds featuring the general formula (I) or (II). These compounds, aimed at GABAα5 PAM, highlight Knust's innovative approach towards developing pharmacological solutions.

Career Highlights: Knust's exceptional career spans across renowned companies like Hoffmann-La Roche Inc., where he has contributed significantly to the field of innovation. His expertise and dedication have not only led to numerous successful inventions but have also established him as a trailblazer in the industry.

Collaborations: Knust has had the privilege of working alongside esteemed colleagues such as Matthias Heinrich Nettekoven and Andrew William Thomas. These collaborations have enabled Knust to leverage diverse perspectives and expertise, resulting in groundbreaking innovations that have left a lasting impact.

Conclusion: Henner Knust's remarkable journey as an inventor epitomizes the relentless pursuit of innovation and sustainability. His vast contributions to the field, coupled with his collaborative spirit and visionary approach, continue to shape the landscape of inventing. Knust's legacy serves as a beacon of inspiration for aspiring inventors and underscores the transformative power of dedication and ingenuity in creating a better future for all.

This text is generated by artificial intelligence and may not be accurate.